-
821
Endovascular treatment of common hepatocellular carcinoma: the experience of one center
Published 2022-02-01Subjects: “…hepatocellular carcinoma; chemoembolization.…”
Get full text
Article -
822
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
Published 2024-03-01“…This review explores the evolution of cancer staging, focusing on intermediate hepatocellular carcinoma (HCC), and the challenges faced by physicians. …”
Get full text
Article -
823
The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes
Published 2023-03-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
824
Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
Published 2020-02-01Subjects: Get full text
Article -
825
Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
Published 2021-02-01Subjects: Get full text
Article -
826
Hepatocellular carcinoma: immunohistochemical characteristics of apoptosis and cell proliferation activity
Published 2014-09-01“…Background. Hepatocellular carcinoma which takes about 85% of primary liver cancer, is the most aggressive and prognostically unfavorable tumor. …”
Get full text
Article -
827
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
Published 2006-01-01“…<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed this study with new effective drug combination.…”
Get full text
Article -
828
Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma
Published 2024-01-01Subjects: Get full text
Article -
829
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma
Published 2022-05-01“…However, there was a lack of report on whether and how LXRα plays a role in the development of hepatocellular carcinoma (HCC). In the current study, we found that systemic activation of LXRα in the VP‐LXRα knock‐in (LXRαKI) mice or hepatocyte‐specific activation of LXRα in the VP‐LXRα transgenic mice sensitized mice to liver tumorigenesis induced by the combined treatment of diethylnitrosamine (DEN) and 3,3',5,5'‐tetrachloro‐1,4‐bis (pyridyloxy) benzene (TCPOBOP). …”
Get full text
Article -
830
Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
Published 2022-01-01Subjects: Get full text
Article -
831
Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma
Published 2021-03-01“…Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the second leading cause of cancer-related deaths worldwide. …”
Get full text
Article -
832
Safety of elective hepatectomy performed on weekend for patients with hepatocellular carcinoma
Published 2022-11-01Get full text
Article -
833
Non-alcoholic fatty liver disease-related hepatocellular carcinoma
Published 2023-03-01“…Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of liver disease, is an increasingly common cause of hepatocellular carcinoma (HCC). Several demographic, clinical, and genetic factors contribute to HCC risk in NAFLD patients, which may inform risk stratification scores. …”
Get full text
Article -
834
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
Published 2017-05-01“…Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular carcinoma (HCC). Methods qRT-PCR analysis and western blotting were performed to detect expression levels of genes and proteins related to NHEJ. …”
Get full text
Article -
835
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
Published 2023-09-01Get full text
Article -
836
Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
Published 2022-08-01“…Growing evidence suggests that snoRNAs act as oncogenes or tumor suppressors in hepatocellular carcinoma (HCC) through multiple mechanisms. …”
Get full text
Article -
837
Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma
Published 2023-08-01Subjects: Get full text
Article -
838
Novel insights into HBV‐hepatocellular carcinoma at single‐cell sequencing
Published 2023-12-01Subjects: Get full text
Article -
839
3D‐Epigenomic Regulation of Gene Transcription in Hepatocellular Carcinoma
Published 2022-12-01Subjects: Get full text
Article -
840
Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
Published 2020-12-01Subjects: Get full text
Article